Skip to content

Released Nov 16, 2020, before the open

10-Q filed Nov 19, 2020, 50 days after period end · 0001493152-20-022041

Q3 2020 · 10-Q
Revenue$3.84M+38.8% vs Q3 2019+6.0% vs Q2 2020
Net Income-$408.00KN/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.04N/M vs Q3 2019N/M vs Q2 2020
Gross Profit$1,042,000+24.9%
Operating Income-$567,000N/M
Operating Cash Flowderived-$481,000N/M
Free Cash Flowderived-$556,000N/M
Margins · derived
Gross margin27.1%−3.0 pt vs Q3 2019
Operating margin-14.8%+1.9 pt vs Q3 2019
Net margin-10.6%+4.8 pt vs Q3 2019

What the release said

The release

Same quarter

MetricQ3 2020Q3 2019Q3 2018Q3 2017
Revenue$3.84M$2.77M$2.44M$3.04M
Net Income-$408.00K-$428.00K-$1.06M-$777.00K
EPS Diluted-$0.04-$0.04-$0.09-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR